No Data
SciSparc Ltd. Subsidiary NeuroThera Labs Inc. Completes Acquisition of 54% Stake in CliniQuantum Ltd.
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
Neurothera Labs Inc: MDA EN
Neurothera Labs Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
NeuroThera, Clearmind Advance Non-Hallucinogenic Depression Therapy With New Patent Filing
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration With Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease